Controlling High Blood Pressure (NQF 0018)

eMeasure Name Controlling High Blood Pressure eMeasure Id 76bccfa7-273b-4932-8d4e-5253aa1dc79c
Version number 1 eMeasure Set Id aa066eed-e8f6-4fec-8084-61d3d1e8b6e2
Available Date No information Measurement Period January 1, 20xx through December 31, 20xx
Measure Steward National Committee for Quality Assurance
Endorsed by National Quality Forum
Description The percentage of patients 18-85 years of age who had a diagnosis of hypertension and whose BP was adequately controlled during the measurement year.
Copyright
© National Committee for Quality Assurance. All Rights Reserved
Measure scoring Proportion
Measure type Process
Stratification
None
Risk Adjustment
None
Data Aggregation
Rationale
This measure assesses the percentage of patients demonstrating adequate control of systolic and diastolic blood pressure levels. Over 50 million Americans warrant treatment for high blood pressure, according to the NHANES survey (JNC-7 2003). Financially, hypertension and associated disorders and heath complications, such as coronary heart disease and congestive heart failure, cost the U.S. economy more than $100 billion each year. The United States Preventive Services Task Force (USPSTF) recommends that clinicians screen adults 18 and older for high blood pressure (2007). This guideline is further endorsed by research studies and clinical trials that have demonstrated decline in costly health outcomes as a direct result of improved blood pressure control. This measure is important in efforts to promote blood pressure control and improve quality of life.
Clinical Recommendation Statement
The U.S. Preventive Services Task Force (USPSTF) recommends screening for high blood pressure in adults age 18 years and older. This is a grade A recommendation JNC-7: Treating SBP and DBP to targets that are <140/90 mmHg is associated with a decrease in CVD complications.
Improvement notation
Higher score indicates better quality
Measurement duration
12 month(s)
Reference
U.S. Preventive Services Task Force. Screening for high blood pressure: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med 2007 Dec 4;147(11):783-6.
Reference
Prevention, Detection, Evaluation, and Treatment of High Blood Pressure The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. NIH Publication No. 035233 December 2003.
Definition
Initial Patient Population(s): All patients aged 18 to 85 years of age during the measurement period
Definition
Denominator(s): Patients in the initial population who had a diagnosis of hypertension during an outpatient encounter within the first six months of the measurement period
Definition
Denominator Exclusion(s): Patients with evidence of end-stage renal disease (ESRD) or active pregnancy during the measurement period
Definition
Numerator(s): The number of patients whose blood pressure was<140/90 during the most recent outpatient encounter
Definition
Denominator Exception(s): N/A
Guidance
In reference to the numerator element, only blood pressure readings performed by a clinician in the provider office is acceptable for numerator compliance with this measure.  Blood pressure readings from the patient's home (including readings directly from monitoring devices) are not acceptable.
Supplemental Data Elements
Report "Patient Characteristic: Gender" using "Gender HL7 Value Set (2.16.840.1.113883.1.11.1)"; Report "Patient Characteristic: Race" using "Race CDC Value Set (2.16.840.1.114222.4.11.836)"; Report "Patient Characteristic: Ethnicity" using "Ethnicity CDC Value Set (2.16.840.1.114222.4.11.837)"; Report "Patient Characteristic: Payer" using "Payer Source of Payment Typology Value Set (2.16.840.1.113883.3.221.5)".

Table of Contents


Population criteria

Data criteria (QDM Data Elements)

Supplemental Data Elements




Measure set CLINICAL QUALITY MEASURE SET 2011-2012